Pharmaceutical

Blue Earth and Seibersdorf expand radiopharmaceutical manufacture deal

Blue Earth Therapeutics' collaboration with Seibersdorf Labor will include the production of investigational 225Ac-based radioligand therapy.

Aug 13, 2024 - 04:00
Blue Earth and Seibersdorf expand radiopharmaceutical manufacture deal
Blue Earth Therapeutics' collaboration with Seibersdorf Labor will include the production of investigational 225Ac-based radioligand therapy.
Read the original article

Tags:

Previous Article

FDA approves IASO Bio’s IND for equecabtagene autoleucel

Next Article

Era of ADCs: Pharma companies innovate to stand out in a buzzing market

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Risk adjusted net present value: What is the current va...

Jul 2, 2024

STAT+: Pharmacies fear New Year’s financial squeeze from Biden administration rule

STAT+: Pharmacies fear New Year’s financial squeeze fro...

Jan 2, 2024

The changing of the guard is expected in the Crohn’s disease marketplace

The changing of the guard is expected in the Crohn’s di...

Sep 1, 2023